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Purpose: Technology-assisted interventions are essential in supporting cancer survivors’ psychosocial out-
comes, especially for childhood, adolescent, and young adult (AYA) cancer survivors, a tech-savvy generation.
This study aims to systematically evaluate review and meta-analyze technology-assisted interventions for
childhood and AYA cancer survivors.
Methods: Following the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA)
guidelines, the study team used a pre-set of key words and searched studies across 11 electronic databases and 4
professional websites, and conducted a manual search of reference lists from published reviews. Meta-analysis
of small sample size corrected Hedges’ g was conducted using meta-regression with robust variance estimation.
Results: Final analysis included a total of 28 clinical trials, including 237 effect sizes reported an overall sta-
tistically significant treatment effect of technology-assisted psychosocial interventions for childhood and AYA
cancer survivors, g = 0.382, 95% confidence interval (CI) 0.243 to 0.521, p < 0.0001. Subgroup analysis revealed
that distraction-based interventions and interventions for psychosocial and emotional health were overall sta-
tistically significant, whereas interventions for childhood and AYA cancer survivors’ cancer knowledge out-
comes and physical and functional health outcomes were statistically nonsignificant. Moderator analysis found
intervention target was a significant moderator.
Conclusions: Technology-assisted interventions for childhood and AYA cancer survivors were overall effective
across domains of survivorship outcomes. Favorable evidence was found primarily for childhood cancer sur-
vivors with limited support for AYA cancer survivors.
Implications for Cancer Survivors: Although existing technology-assisted interventions are overall promising,
research support for cancer survivors from different age groups and with different psychosocial challenges
varies and should be considered individually.
Keywords: technology-assisted intervention, childhood and AYA cancer, survivorship outcomes, meta-analysis
Introduction
Cancer is the leading cause of disease-related deathpast infancy among children and adolescents and young
adults (AYAs) in the United States and across the globe.1,2
In the United States, *11,000 and 89,500 new cancer diag-
noses were estimated for children (0–14 years of age) and
AYA patients (15–39 years of age) in 2020, respectively.2,3
Advances in the therapeutic and supportive care have im-
proved the overall 5-year cancer survival rate among children
and AYAs to 80% or higher,4,5 which has resulted in a large
and growing population of childhood and AYA cancer sur-
vivors.6,7 As the prognosis for childhood and AYA cancer
patients continues to improve, increased attention has been
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focused on the health-related quality of life (HRQoL), in-
cluding psychosocial, behavioral, and functional health,
among members of this population.8,9
Indeed, studies have reported that over 60% of childhood
and AYA cancer survivors experience adverse psychosocial,
behavioral, and functional health outcomes that compro-
mise their HRQoL for many years after completion of can-
cer treatment.10 Key challenges affecting survivors’ HRQoL
include the following: (1) distressing experiences during
active invasive cancer treatment (e.g., fear, pain, and nau-
sea)11,12; (2) psychosocial and emotional challenges both
during and after treatment, including psychological distress,
fear of recurrence, infertility, and reproductive/sexual health
challenges13–15; (3) limited knowledge about and engage-
ment in survivorship care16–18; and (4) impaired physical
and functional health due to adverse and late effects of cancer
treatment.19–21 If left unaddressed, these challenges have
been found to be associated with childhood and AYA cancer
survivors’ disengagement from survivorship care, reduced
self-efficacy, increased risk health behaviors, including sui-
cide, and compromised HRQoL.19,22–26
While effective interventions are available for childhood
and AYA cancer survivors’ psychosocial, behavioral, and
functional health,27,28 these interventions often fail to reach
the population in need. First, there is a significant psycho-
oncology workforce shortage supporting childhood and AYA
cancer survivors,29,30 resulting in many childhood and AYA
survivors not having access to essential psycho-oncology
care such as depression treatment or functional rehabilita-
tion. Second, even for childhood and AYA survivors who have
access to psycho-oncology services, high proportions of these
patients drop out of services, and compared with their younger
and older counterparts, AYA survivors are the most likely to
disengage from supportive cancer care due to their unique de-
velopmental and cancer treatment features, that is, the tran-
sition of their care from pediatric to medical oncology.31,32
Given the above-mentioned challenges, technology-
assisted psychosocial interventions have received increased
attention among psycho-oncology practitioners and research-
ers as the result of several major strengths. In this article, due
to a lack of agreed-upon typology/taxonomy of technology-
assisted health interventions,33 we broadly define technology-
assisted interventions as any type of intervention that involves
the use of technology, ranging from text messages and
wearable devices to computers and virtual reality devices.
We define psychosocial interventions broadly as any type of
intervention that is not solely medical and/or pharmacologi-
cal, for example, psychotherapeutic interventions, psychoe-
ducational interventions, behavioral skills training, and peer
support groups. Technology-assisted psychosocial interven-
tions have important potential in reducing barriers to access,
which can allow services to be delivered at patients’ preferred
location and time.34,35 More importantly, as members of a
tech-prone and tech-savvy generation, childhood and AYA
cancer survivors are more likely to engage in technology-
assisted psychosocial interventions, as many of these in-
terventions are delivered in their preferred methods of
communication (e.g., social media-based peer support groups
or text messages to improve treatment compliance).36,37
Finally, recent advances in machine learning and artificial
intelligence have enabled key innovations in the delivery of
psycho-oncology care for childhood and AYA cancer survi-
vors. For example, psycho-oncology researchers have started
to explore the use of machine learning models to inform AYA
cancer survivors’ survivorship care planning.38
Considering the major strengths and important potential
of technology-assisted psychosocial interventions for child-
hood and AYA cancer survivors across cancer centers and
geographic locations, it is critical to systematically evaluate
technology-assisted psychosocial interventions to guide the
field of psycho-oncology and inform future research on sur-
vivorship care. To our knowledge, three relevant reviews
have been conducted to date: two narrative systematic re-
views of digital health (or mHealth) interventions, one for
childhood and the other for AYA cancer survivors,39,40 and
one meta-analysis focusing on distance-delivered physical
activity interventions for childhood cancer survivors.28 The
two review articles39,40 concluded that technology-assisted
interventions are acceptable to and feasible for pediatric
and AYA cancer survivors in general and called for future
research to focus on formally evaluating the efficacy of
technology-assisted interventions. In addition, Mizrahi
et al.28 meta-analyzed four clinical trials of distance-
delivered physical activity interventions for childhood cancer
survivors and found preliminary evidence supporting their
benefits for physical function and psychological outcomes,
but not for physical activity and physiological outcomes.
These three highly valuable studies consistently called for
investigators to do the following: (1) conduct a meta-analysis
to formally evaluate the efficacy of technology-assisted in-
terventions for pediatric and AYA survivors; (2) include
various technology-assisted interventions targeting various
outcome domains, as they often interact with each other
and coexist; and (3) evaluate key moderators, if data allow,
such as cancer survivors’ age or race in relation to treat-
ment effect size, which will deepen the understanding of
whether certain interventions are better tailored to respond to
the unique needs of specific patient populations.
In response to key gaps in the literature, this work reports
on the systematic review and meta-analysis of technology-
assisted psychosocial interventions for childhood and AYA
cancer survivors, including multiple domains of survivorship
outcomes (defined later in the inclusion criteria). In this re-
view, a person is considered a cancer survivor from the time
of diagnosis until the end of life, that is, it includes child-
hood and AYA cancer patients both during and after cancer
treatment.41 Our primary hypothesis is that technology-
assisted psychosocial interventions are effective overall
for childhood and AYA cancer survivors across multiple
survivorship outcome domains. We also examine whether the
interventions are effective for specific outcome domains when
evaluated separately. Finally, we explore whether any impor-
tant study, intervention, or participant characteristics (e.g.,
age, race, treatment length, and study design) moderates the
treatment effect size of technology-assisted interventions.
Methods
This study was conducted following Preferred Reporting
Items for Systematic Review and Meta-Analysis (PRISMA)
guidelines,42 by an investigative team equipped with ex-
pertise in pediatric and AYA psychosocial oncology, can-
cer survivorship, and procedures for conducting systematic
review and meta-analysis.


















































Search procedure and study eligibility
The study team performed a systematic search of con-
trolled clinical trials (with or without random participant
assignment) that evaluated technology-assisted psychosocial
interventions for pediatric and/or AYA cancer survivors.
Specifically, 11 electronic databases, 4 professional websites,
and a manual search of reference lists from published reviews
(30 systematic reviews and 6 meta-analysis studies) were
used to generate an initial pool of studies for screening
(Supplementary Appendix SA1). To identify studies focus-
ing on childhood and AYA cancer survivors, we searched
using the following key terms: ‘‘childhood cancer’’ or
‘‘pediatric cancer’’ or ‘‘childhood oncology’’ or ‘‘pediatric
oncology’’ or ‘‘adolescent and young adult’’ or ‘‘AYA’’ or
‘‘young adult cancer’’ or ‘‘young adult oncology’’ or ‘‘youth
cancer’’ or ‘‘youth oncology.’’ To identify studies that eval-
uated psychosocial interventions, we used the key terms
‘‘psychological’’ or ‘‘social’’ or ‘‘psycho*’’ or ‘‘behavior*’’
or ‘‘support*’’ or ‘‘education*’’ or ‘‘training.’’
All studies published in English were searched from in-
ception to August 1, 2020 (the date the initial search was
completed). To be eligible for inclusion, a study needed to
(1) be a controlled trial (with or without randomization); (2)
evaluate one or more psychosocial intervention(s); (3) target
pediatric, adolescent, and/or young adult cancer survivors
(i.e., individuals 0–39 years of age with a cancer diagnosis);
and (4) utilize technology in the delivery of the intervention,
including those that used technology as the primary mode of
treatment delivery (e.g., virtual reality goggles) and those that
used technology in an assistive role (e.g., text messaging).
The study could target any outcome in childhood and AYA
cancer survivors, ranging from physical (e.g., pain and
tremor) and psychological (e.g., depression and distress)
outcomes to quality of life, cancer knowledge, and social
relations (e.g., self-isolation) outcomes. Studies were exclu-
ded only if they evaluated medical or pharmaceutical treat-
ment, there was no comparison/control group in the study,
or there was no outcome data on intervention efficacy or
effectiveness.
Data extraction
A data extraction sheet was pre-developed by the study
team to systematically code and extract information for all
included studies (available upon request from the first au-
thor). Two research assistants independently screened all
studies first by reading study titles and abstracts, and then
by reading the full text of the remaining articles using
Covidence, a Cochrane-recommended screening platform.
Disagreements between the two research assistants were re-
solved by consensus first, and, if not successful, through
discussion with a third/senior study team member. Inter-
screener reliability was 92% and inter-reviewer reliability
was 89%, both of which indicated satisfactory reliability.
Publication bias and quality of study assessment
Publication bias was assessed using the Cochrane
Collaboration’s Risk of Bias Tool, version 2 (RoB 2),43 for
randomized controlled trials, and the Risk of Bias in Non-
randomized Studies—of Interventions (ROBINS-I) tool for
controlled trials without randomization.44 Both tools evalu-
ate key aspects/domains of clinical trial studies that are
subject to research bias, such as the randomization process,
the handling of missing data, and the selective reporting
of data. Each study was evaluated using a three-category
response: ‘‘+’’ = low risk of bias, ‘‘?’’ = unsure/moderate
risk of bias, or ‘‘ · ’’ = serious or critical risk of bias. Pub-
lication bias was assessed visually using a funnel plot and
statistically using Vevea and Woods’ sensitivity analysis
using a priori weight functions.45 A reasonably symmetric
funnel plot—in which both statistically significant and in-
significant effect sizes are included and analyzed—is a sign
of no publication bias. Vevea and Woods’ sensitivity analy-
sis calculates an observed effect size and a theoretical effect
size assuming the funnel plot is symmetric (i.e., there is no
publication bias). If the distance between the two lines is not
statistically significant, it can be viewed as supporting no
publication bias.
Meta-analytic procedures
All trial outcomes were continuous variables and small
sample size corrected Hedges’ g was calculated to reflect
standardized mean difference effect size.46 The sampling
variance of Hedges’ g was obtained as a function of the g
and its associated sample size.46 Meta-analysis was con-
ducted using meta-regression with robust variance estimation
(RVE).47 Meta-regression with RVE was chosen because of
the clustered nature of the data. Specifically, multiple effect
sizes of the same construct were reported in a single study,
which created dependence among those effect sizes from the
same study. Meta-regression with RVE effectively handles
the dependence among effect sizes from the same study
without excluding these effect sizes.47,48 Furthermore, meta-
regression with RVE produces unbiased estimates of an
overall treatment effect size that is robust across different
variance assumptions, that is, robust for both fixed- and
random-effects models. In addition to estimating an overall
treatment effect size, we also planned subgroup analyses
and moderator analyses based on important intervention and
patient characteristics, for example, the role of technology,
the treatment modality, and patients’ age.
Specifically for moderator analyses, we conducted uni-
variate meta-regression analysis with the following: (1) key
patient demographic variables (i.e., cancer patients’ age, sex,
racial background, treatment stage, and current treatment
received, if applicable); (2) key study design variables, that
is, randomization (random vs. nonrandom assignment), type
of comparison (e.g., active treatment vs. treatment-as-usual
vs. waitlist or attention control); and (3) intervention char-
acteristics, that is, intervention modality, targeted outcome,
nature of intervention (e.g., psychotherapeutic vs. supportive
intervention), role of technology, and human clinician in-
volvement. One caveat in understanding results from meta-
regression with RVE is that when a statistic has a degree of
freedom lower than 4, a stricter p value (i.e., p < 0.01) should
be used for interpreting statistical significance. Due to the fact
that during the course of this study, we conducted multiple
statistical tests using the same data and thus needed to adjust
for an inflated Type I statistical error, in this article, we
consider a p-value of 0.01 as being statistically significant
for all result interpretations. Sensitivity analyses were con-
ducted to account for risk of bias and outliers to ensure that


















































findings did not significantly change. All data analyses were
conducted using R Statistical Software (version 4.0.3) with
the ‘‘metaphor’’ and ‘‘robumeta’’ packages.
Results
Search results and study characteristics
A total of 10,026 records were retrieved from electronic
database and manual searches after duplications were re-
moved. Title and abstract screening excluded 9932 studies
that clearly did not meet inclusion criteria, leaving 94 studies
for full text eligibility screening. Sixty-six studies were fur-
ther excluded for various reasons (see Fig. 1 notes), resulting
in a final analytical sample size of 28 clinical trials.
The 28 trials included 237 effect size estimates and a total
sample size of 2006 childhood and AYA survivors (Table 1).
Trials were published between 1987 and 2019, including
1 published in 1987, 6 published between 2000 and 2010,
12 published between 2011 and 2015, and 9 published be-
tween 2016 and 2019. Participants’ average age ranged from
9 to 32 years, with 16 studies (109 effect sizes) focusing on
childhood cancer survivors, 9 studies (100 effect sizes) fo-
cusing on AYA cancer survivors, and 3 studies (28 effect
sizes) focusing on both. In the trials that reported patients’
sex (n = 27), 47% of the patients were female (n = 920), and
25 studies reported a total of 902 Caucasian participants
(55.66%). Twenty-two out of 28 trials (78.6%) included
childhood and AYA cancer survivors with different cancer
diagnoses, leaving 6 trials that included childhood and AYA
cancer survivors with only one diagnosis. All but two studies
were randomized controlled trials and two were controlled
trials without randomization.
Most clinical trials (15 studies, including 89 effect sizes)
reported psychosocial and emotional health outcomes among
childhood and AYA cancer survivors. Five studies (25 effect
sizes) reported the outcome of distracting childhood and
AYA survivors from invasive cancer treatment, leaving
6 studies (80 effect sizes) and 8 studies (43 effect sizes) that
focused on the outcomes of cancer-related knowledge and
functional health among childhood and AYA survivors,
respectively.
Over 80% of the studies (n = 22) used technology as the
primary intervention or in the venue of the intervention de-
livery, while 6 studies used technology as an assistive tool
for intervention, for example, use of text messages for
between-session check-ins. Over half of the interventions
(n = 19, or 67.9%) were individual-based interventions and
the remainder were group-based interventions. Thirteen
studies involved a human clinician as the primary provider,
while 15 studies involved a human clinician (in an assistive
role) for logistic or administrative check-in purposes. Var-
ious technologies were used across studies, such as tablets,
cellphones, computers/laptops, Fitbits/wearables, and virtual
reality devices (e.g., goggles), among others.
Publication bias and risk of bias
The funnel plot for publication bias (Fig. 2) was reasonably
symmetric, which indicated low concern for publication bias.
The Vevea and Woods’ sensitivity weight model supported
the absence of publication bias with the observed overall
treatment effect size (red line) not significantly different
from a theoretical overall treatment effect size (blue line),
assuming the funnel plot is symmetric. Risk of bias assess-
ment (Table 2) identified overall low risk of bias for both the
randomized controlled trials and the controlled trials without
randomization in the study. Unsure or moderate risk of bias
arising from the randomization process and bias due to
missing outcome data were identified in several of the trials.
No other concern about risk of bias was present.
FIG. 1. Literature search
flow diagram.


















































Meta-analytic and subgroup analysis results
Synthesizing across the 28 clinical trials (including the
237 effect sizes) yielded an overall treatment effect size for
technology-assisted psychosocial interventions for childhood
and AYA cancer survivors of g = 0.382, 95% confidence in-
terval (CI) (0.243 to 0.521), p < 0.0001 (Table 3). Thus,
childhood and AYA cancer survivors receiving technology-
assisted interventions on average were expected to experi-
ence a 0.382 standard deviation greater improvement than
their counterparts in the control condition. Subgroup analysis
revealed that distraction-based interventions and interven-
tions for psychosocial and emotional health reported overall
statistically significant treatment effects: g = 0.769, 95% CI
(0.406 to 1.130), p = 0.0052 and g = 0.299, 95% CI (0.105 to
0.494), p = 0.0060, respectively. Technology-assisted inter-
ventions for childhood and AYA cancer survivors’ cancer
knowledge outcomes and physical and functional health
outcomes were not statistically significant: g = 0.197, 95% CI
(0.031 to 0.364), p = 0.0317 and g = 0.269, 95% CI (0.014 to
0.523), p = 0.0416, respectively.
Studies reported overall statistically significant treatment
effects regardless of treatment modality, that is, in both
individual- and group-based interventions: g = 0.315, 95% CI
(0.134 to 0.497), p = 0.0023 and g = 0.481, 95% CI (0.246 to
0.716), p = 0.0017, respectively. Similarly, studies reported
overall statistically significant treatment effects regardless
of level of human involvement, that is, in those involving a
human as a primary intervention provider and those involving
a human for logistic/administrative check-in: g = 0.466, 95%
CI (0.244 to 0.688), p = 0.0007 and g = 0.296, 95% CI (0.115
to 0.478), p = 0.0043, respectively.
Studies that used technology as the primary intervention or
primary method of intervention delivery reported an overall
statistically significant treatment effect: g = 0.419, 95% CI
(0.255 to 0.583), p < 0.0001. In contrast, studies that used
technology as a complementary or assistive tool reported an
overall treatment effect that was not statistically significant:
g = 0.274, 95% CI (-0.104 to 0.561), p = 0.1200. The overall
treatment effect of technology-assisted interventions deliv-
ered as psychotherapeutic treatments was not statistically
significant: g = 0.455, 95% CI (-0.259 to 1.170), p = 0.140,
whereas technology-assisted interventions delivered as non-
psychotherapeutic treatments (e.g., distraction or peer sup-
port) had an overall statistically significant treatment effect:
g = 0.369, 95% CI (0.223 to 0.515), p < 0.0001.
Studies delivering technology-assisted interventions for
childhood cancer survivors only had an overall statistically
significant treatment effect: g = 0.414, 95% CI (0.184 to
0.645), p = 0.0019. Studies delivering technology-assisted
interventions for AYA cancer survivors only or for childhood
and AYA cancer survivors had overall treatment effects that
were not statistically significant: g = 0.283, 95% CI (0.053 to
0.514), p = 0.0229 and g = 0.600, 95% CI (0.214 to 0.986),
p = 0.0222, respectively.
Table 1. Descriptive Summary





Between 2001 and 2010 6
Between 2011 and 2015 12
Between 2016 to present 9
Age of study participants (mean) 28
Age of study participants (range) 28 4.2–32.17
Gender (% female) 27 45.86%
Targeted population
Childhood cancer survivors only 16 109 ES
AYA cancer survivors only 9 100 ES










Cancer related knowledge 6 80 ES





Technology has a primary role
in intervention
22
Technology has an assistive role
in intervention
6
Involvement of human clinician
Primary provider of intervention 13





including DVD or Videos
8
Web-based, including Facebook 4
Interactive chatbot 3
(Educational) video games 4






AYA, adolescent and young adult; ES, effect sizes.
FIG. 2. Funnel plot for publication bias.



















































The heterogeneity statistic, Q (236) = 647.44, p < 0.0001,
indicated a significant amount of heterogeneity across effect
size estimates, which warranted further moderator analy-
ses (Table 4). Single-predictor univariate meta-regression
analyses identified one significant moderator, intervention
targets. When compared with distraction-based technology-
assisted interventions, cancer knowledge outcomes (b = -0.546,
p = 0.0065) and physical and functional health outcomes
(b = -0.547, p = 0.0045) had significantly lower treatment ef-
fects, (i.e., these interventions were less effective). No other
moderators evaluated were identified in this review.
Discussion
Overall, technology-assisted interventions are promising
in supporting childhood and AYA cancer survivors’ psy-
chosocial health across multiple domains. In this systematic
review and meta-analysis, we identified an overall statisti-
cally significant treatment effect in relation to digital health
interventions for childhood and AYA cancer survivors’ dis-
tress and psychological wellness, but not for cancer-related
knowledge or functional health outcomes. While the overall
significant treatment effect was encouraging, oncologists and
psycho-oncology providers need to critically evaluate avail-
able research evidence when considering technology-assisted
interventions for different patient outcomes among pediatric
and AYA cancer survivors. In other words, as indicated by
the findings in this review, providers should not consider
technology-assisted interventions effective for all outcome
domains in pediatric and AYA cancer survivors, especially
for improvements in cancer-related knowledge and func-
tional health.
Digital health interventions that distract patients from in-
vasive cancer treatments have received the strongest research
support, evidenced by a statistically significant, large treat-
ment effect. In addition, this study has shown that treatment
effects for digital health interventions targeting childhood
Table 2. Risk of Bias for Randomized Controlled Trials and Controlled Trials Without Randomization
Randomized controlled trials
Study citation BARP BDII BMOD BMO BSRR
Akard et al. (2015) + + ? + +
Alemi et al. (2016) ? + ? + +
Beale et al. (2007) ? + ? + +
Burns et al. (2009) ? + + + +
Casillas et al. (2019) + + ? + +
Conklin et al. (2015) + + ? + +
Fazelniya et al. (2017) + + ? + +
Gershon et al. (2004) + + ? + +
Greer et al. (2019) + + + + +
Hardy et al. (2013) ? + ? + +
Howell et al. (2018) ? + ? + +
Huang et al. (2014) + + + + +
Jones et al. (2010) ? + ? + +
Kato et al. (2008) + + + + +
Klosky et al. (2004) ? + ? + +
Kunin-Batson et al. (2016) + + ? + +
Mays et al. (2011) ? ? + + +
Mendoza et al. (2017) ? + + + +
Palmer et al. (2014) ? + + + +
Rabin et al. (2011) ? + + + +
Robb et al. (2014) ? + + + +
Sabel et al. (2016) ? + ? + +
Valle et al. (2013) + + + + +
Wolitzky et al. (2005) ? + ? + +
Wu et al. (2018) ? + ? + +
Yeh et al. (2011) ? + ? + +
No. of studies (out of 26 studies) with low risk of bias 10 25 10 26 26
No. of studies (out of 26 studies) with unsure/moderate risk of bias 16 1 16 0 0
No. of studies (out of 26 studies) with serious or critical risk of bias 0 0 0 0 0
Controlled trials without randomization
BC BSPS BCI BDII BMOD BMO BSRR OB
Li et al. (2011) + + + + ? + + +
Redd et al. (1987) + + + + ? + + +
‘‘+’’ = low risk of bias; ‘‘?’’ = unsure/moderate risk of bias.
BARP, bias arising from the randomization process; BC, bias due to confounding; BCI, bias in classification of interventions; BDII, bias
due to deviations from intended interventions; BMO, bias in measurement of the outcome; BMOD, bias due to missing outcome data;
BSPS, bias in selection of participants into the study; BSRR, bias in selection of the reported result; OB, overall bias.


















































and AYA cancer survivors’ cancer knowledge and functional
health are not significant. It may be that our findings on the
lack of significant treatment effects of interventions target-
ing survivors’ cancer knowledge were caused by the small
number of studies involved, (i.e., evidenced by low degrees
of freedom). However, our findings on digital health inter-
ventions for childhood and AYA survivors’ functional health
outcomes are consistent with a previous meta-analysis, which
found that a distance-delivered physical activity intervention
did not increase childhood cancer survivors’ physical activ-
ity, but may improve their physical and functional health.28
Therefore, future research in survivorship care for childhood
and AYA survivors should focus on the use of technology-
assisted interventions in these areas and revisit the topics
when more studies become available.
Furthermore, moderator analysis found that treatment
effects for cancer knowledge and patients’ functional health
were both significantly smaller (i.e., less effective) than those
for distraction-based technological interventions. One pos-
sible factor that may contribute to the difference in targeted
outcomes (i.e., distraction-based interventions vs. knowl-
edge or functional health outcomes) is the technology used.
Many distraction-based interventions have employed advan-
ced technologies such as virtual reality goggles or interac-
tive chatbot, whereas interventions to improve cancer-related
knowledge have employed psycho-educational computer
programs or text messages as the primary technology.49 It is
possible that virtual reality technologies are more engaging
for childhood and AYA cancer survivors and that older
technologies (e.g., text messaging) are less attractive among
this population. As a result, the smaller treatment effects
produced by these interventions are possibly caused by par-
ticipants’ poor engagement in these interventions. In addi-
tion, it is also possible that interventions with advanced
technology are likely to have greater tailorability to patients’
individual needs, whereas interventions targeting cancer
knowledge or functional health are more structured and thus
less suited to personalization. Future researchers should be
mindful of developing and implementing engaging digital
health interventions for childhood and AYA cancer survi-
vors, especially those platforms that have a high potential for
individualization and tailorability.50
Table 3. Overall Treatment Effect and Subgroup Treatment Effects
Estimate K/Na dfsb 95% CI p
Overall effect 0.382 28/237 23.4 0.243 to 0.521 <0.0001
Intervention targets
Distraction of intrusive treatment 0.769 5/25 3.48 0.406 to 1.130 0.0052
Psychosocial and emotional health 0.334 15/89 12.5 0.120 to 0.547 0.0051
Cancer knowledge 0.197 6/80 3.39 0.031 to 0.364 0.0317
Physical and functional health 0.269 8/43 6.03 0.014 to 0.523 0.0416
Treatment modality
Individual based 0.315 19/124 14.1 0.134 to 0.497 0.0023
Other or mixed format 0.481 9/113 7.52 0.246 to 0.716 0.0017
Role of technology
Primary intervention 0.419 22/178 17.8 0.255 to 0.583 <0.0001
Secondary assistive role 0.274 6/59 4.8 -0.104 to 0.651 0.1200
Human clinician involvement
Human as primary provider 0.466 13/157 10.9 0.244 to 0.688 0.0007
Human provides logistic check-in 0.296 15/80 10.6 0.115 to 0.478 0.0043
Intervention nature
Therapeutic intervention 0.455 5/31 3.24 -0.259 to 1.170 0.1400
Non-therapeutic intervention 0.369 23/206 19.5 0.223 to 0.515 <0.0001
Patient group
Childhood cancer survivor only 0.414 16/109 12.8 0.184 to 0.645 0.0019
AYA cancer survivor only 0.283 10/104 6.89 0.053 to 0.514 0.0230
Childhood and AYA survivors 0.600 3/28 1.92 0.214 to 0.986 0.0222
aK = number of studies; N = number of effect size estimates.
bdfs, degrees of freedom. If dfs <4, a stricter p-value of 0.01 should be used as threshold for statistical significance.
CI, confidence interval.
Table 4. Univariate Meta-Regression Moderator Analysis
Estimate K/N dfsa 95% CI p
Intervention targets
Distraction from intrusive treatment (ref.) 0.766 28/237 3.61 0.411 to 1.121 0.0047
Psychosocial and emotional health -0.367 28/237 6.72 -0.758 to 0.025 0.0623
Cancer knowledge -0.546 28/237 6.89 -0.882 to -0.209 0.0065
Physical and functional health -0.547 28/237 8.77 -0.875 to -0.219 0.0045
adfs, degrees of freedom.
ref., reference group.


















































Treatment effects were statistically significant regardless
of treatment modality (individual vs. nonindividual inter-
vention) and the involvement of a human clinician (a human
clinician as the primary interventionist vs. a human clinician
providing logistic and supportive check-in). These findings
are encouraging as they provide preliminary support for a
variety of methods of delivering technology-assisted inter-
ventions to childhood and AYA cancer survivors and all can
be equally effective. In contrast, however, only those inter-
ventions that used technology as the primary intervention
(as opposed to using it in an assistive role) had statistically
significant treatment effects. Studies included in this review
used various technologies in supporting childhood and AYA
cancer survivors ranging from text messages and Facebook
chats (often in assistive roles) to virtual reality goggles and
active video games (often as the primary intervention). It
seemed that advanced technologies that are used as an in-
dependent intervention have greater potentials than using
technologies in assistive roles for childhood and AYA cancer
survivors.
The overall treatment effect of tech-based psychothera-
peutic interventions was not statistically significant, which
revealed an important gap in existing childhood and AYA
cancer survivorship research. Psychotherapeutic interven-
tions (such as cognitive behavioral therapy) are often deliv-
ered in a (semi)structured way to ensure treatment fidelity.
When transferred to a technology-assisted platform, it is
likely that some key components may be lost or insufficient
during the process, which further compromises treatment fi-
delity and intervention effect. This suggests an important
caveat for future psychosocial oncology studies: researchers
must endeavor to ensure both engagement and fidelity when
developing and implementing technology-assisted psycho-
therapeutic interventions to address psychological and emo-
tional outcomes among childhood and AYA cancer survivors.
In addition, the treatment effect of technology-assisted
interventions was only statistically significant across studies
focused on pediatric cancer survivors and not across studies
focused on AYA cancer survivors or childhood and AYA
cancer survivors combined. In other words, technology-
assisted interventions overall were not effective for AYA
cancer survivors, a finding that is consistent with other
studies.51 This may be perceived as a counterintuitive finding
because AYAs, a tech-savvy generation, are often deemed
‘‘ideal candidates’’ for digital health interventions. One pos-
sible explanation for the discrepancy is that AYAs’ appraisal
of engaging technologies may be more demanding compared
with their pediatric and adult counterparts. In other words,
technology-based interventions that are considered engaging
and appealing for pediatric and adult cancer survivors may be
perceived as less attractive to AYA survivors, which could
potentially contribute to a lower treatment effect (due to poor
engagement). Also, it is also possible that AYA cancer sur-
vivors experience additional challenges and distress during
their transition from pediatric to medical oncology. These
challenges may make them less responsive to technology-
assisted interventions, and many of these challenges require
attention from health care systems and in health policies.
While advances in technology have a major potential to
improve the accessibility of psychosocial interventions for
all cancer survivors, including AYAs, investigators should
carefully consider other key aspects of technology-assisted
treatment development, namely treatment fidelity and treat-
ments’ interactivity and engagingness for AYAs.50 Inves-
tigators of technology-assisted interventions for AYA cancer
survivors should adopt an interdisciplinary approach in de-
veloping technology-assisted platforms to improve inter-
activity and engagement, employing psycho-oncologists,
computer scientists, media specialists, developmental psy-
chologists, game designers, and specialists in other relevant
disciplines. It is also essential for researchers and clinicians to
incorporate the social determinants of health and health dis-
parities in designing technology interventions supporting
AYAs, given the unique transition-of-care challenges that are
common among this population.
Finally, both demographic diversity among AYA cancer
survivors and technology, information, and social media use
in the lives of AYAs have been flagged as key components in
developing a forward-looking approach to AYA psycho-
oncology care.15 Therefore, the diversity among users and
the plurality of contexts in which technologies are used must
be critically incorporated into future studies about and
implementation of technology-assisted psychosocial inter-
ventions for AYA cancer survivors. Innovative research
approaches and clinical implementation strategies must ac-
count for health disparities associated with digital exclusion
or ‘‘usage access gaps’’ that AYAs may face.52 Digital in-
equality is produced through variability in access to hardware
and infrastructure, disparate digital skills, the differential
usage/purpose of technology, and variable mental/emotional
associations with technology use. Furthermore, demographic
factors such as age, gender, race, and socioeconomic status
influence the impact of these interrelated barriers (e.g.,
equipment and internet speed) on access to effective tech-
nology use.53 Therefore, demographic factors impacting
digital inequality must be addressed in study design and
service provision.
Strengths and limitations
A couple of limitations are worth noting. First, there is
always a chance that the investigative team may have missed
relevant articles, especially given that technology-assisted
intervention studies may only include terms in their titles and
abstracts that were not included in our search strategy. This
concern, however, was largely alleviated after a thorough
review of other existing systematic review and/or meta-
analysis studies. Second, while our study used advanced
statistical analysis to include multiple effect sizes from each
study to improve statistical power, certain subgroup and
moderator analyses still suffered from low statistical power
(given the small sample size and the low number of effect
sizes), which may have contributed to some findings that
were not statistically significant. Third, our decision to use a
wide age range as well as to include various forms of tech-
nology may confound some overall findings due to hetero-
geneity across studies. Therefore, it is important to interpret
some of our overall findings in conjunction with findings
from subgroup and moderator analyses. It is also worth not-
ing that one included study (by Redd et al.)54 was published
in 1987, while the rest were published in 2004 or later.
Sensitivity analyses with and without inclusion of the study
published in 1987 revealed no change; therefore, the Redd
study was included. However, it is important to keep in mind


















































that the use and definition of technology have changed
drastically since 1987, especially over the past 10 to 15 years.
Finally, many included studies did not clearly differentiate
between interventions that were delivered to childhood or
AYA cancer survivors during treatment or after treatment
(or both), which prevented us from distinguishing treatment
effects of technology-assisted interventions for AYAs cur-
rently receiving treatment from treatment effects of those
who completed therapy.
With that said, in this most recent and comprehensive
systematic review and meta-analysis of technology-assisted
interventions for childhood and AYA cancer survivors, we
have not only used a comprehensive search strategy but also
advanced statistical analyses that included 237 effect size
estimates (across 28 clinical trials) for data synthesis. Given
the substantially improved sample size of this review, both
subgroup and moderator analyses were possible, which al-
lowed a more nuanced interpretation of the existing literature
on survivorship care for childhood and AYA cancer survi-
vors. Given the comprehensiveness of this review, that is, the
inclusion of a large number of studies and effect sizes, con-
fidence was high on the findings we obtained.
Conclusion
This study showed that technology-assisted interventions
for childhood and AYA cancer survivors were overall ef-
fective across domains of survivorship outcomes. Favorable
evidence was found primarily for childhood cancer survivors
with limited support for AYA cancer survivors. Based on
the existing literature, there exists strong research evidence
supporting technology-assisted interventions that distract
childhood and AYA cancer survivors from intrusive cancer
treatment and increase their psychosocial and emotional
well-being. With recent advances in technology and the in-
fluence of social media, future studies need to focus on areas
where evidence remains limited, that is, on areas related to
survivors’ cancer-related knowledge and the improvement of
functional health outcomes.
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